Aceto reported 5.02M in Selling and Administration Expenses for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Selling And Administration Expenses Change
Acasti Pharma ACST:US C$ 1.51M 34K
Aceto ACET:US 5.02M 605K
Agile Therapeutics AGRX:US $ 15.83M 2.76M
Glaxosmithkline GSK:US 2.5B 183M
Idera Pharmaceuticals IDRA:US $ 2.47M 684K
Merk MRK:US $ 2.25B 376M
Novartis NVS:US 3.71B 190M
Pain Therapeutics PTIE:US $ 1.24M 233K
Pfizer PFE:US $ 2.79B 134M
Prestige Brands PBH:US $ 61.91M 1.67M
Quaker Chemical KWR:US $ 108.68M 590K